Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.
Clinical trial NCT01770379 · TERMINATED
Trial details
- NCT number
- NCT01770379
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.